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Abstract: The use of silver in the past demonstrated the certain antimicrobial activity, though 
this has been replaced by other treatments. However, nanotechnology has provided a way 
of   producing pure silver nanoparticles, and it shows cytoprotective activities and possible 
  pro-healing properties. But, the mechanism of silver nanoparticles remains unknown. This 
study was aimed to investigate the effects of silver nanoparticles on bronchial inflammation and 
hyperresponsiveness. We used ovalbumin (OVA)-inhaled female C57BL/6 mice to evaluate the 
roles of silver nanoparticles and the related molecular mechanisms in allergic airway disease. 
In this study with an OVA-induced murine model of allergic airway disease, we found that 
the increased inflammatory cells, airway hyperresponsiveness, increased levels of IL-4, IL-5, 
and IL-13, and the increased NF-κB levels in lungs after OVA inhalation were significantly 
reduced by the administration of silver nanoparticles. In addition, we have also found that the 
increased intracellular reactive oxygen species (ROS) levels in bronchoalveolar lavage fluid 
after OVA inhalation were decreased by the administration of silver nanoparticles. These results 
indicate that silver nanoparticles may attenuate antigen-induced airway inflammation and hyper-
responsiveness. And antioxidant effect of silver nanoparticles could be one of the molecular bases 
in the murine model of asthma. These findings may provide a potential molecular mechanism 
of silver nanoparticles in preventing or treating asthma.
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Introduction
Nanomaterials are a diverse class of small-scale (,100 nm) substances, formed 
by molecular-level engineering and designed to offer unique mechanical, optical, 
electrical, and magnetic properties.1 Recently, much effort has been devoted to the 
development of biomedical applications for nanoparticles (NPs). NPs are also being 
examined for potential medical applications, such as drug delivery, because they are 
able to pass readily through cell membranes.2 Metal NPs have been attracting   increasing 
attention due to their important applications in a number of subject areas, such as 
catalysis and nanoscale electronics.3–6 While significant advances in   biological label-
ing have been made, few therapeutic applications for metal NPs have been reported 
in the literature.7,8 Some noble metal NPs are catalysts for reduction reactions; thus, 
they may be usable as antioxidants, reducing reactive oxygen species (ROS) in the 
living body.9–11 Another candidate material for NPs is silver, which has long been 
known as a strong   antimicrobial agent and disinfectant, which may be due to the 
blockage of the respiratory enzyme pathways, alterations in microbial DNA, and cell 
wall modification.12 Silver has been used for centuries to prevent and treat a variety International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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of diseases, including its use in pleurodesis, cauterization, 
and healing of skin wounds.13,14 The use of silver in the past 
has been restrained by difficulties in the production of pure 
silver compounds, thereby increasing potential side effects. 
Nanotechnology has provided a way of producing pure silver 
NPs. Some studies of silver NPs have demonstrated that they 
exhibit cytoprotective activities toward HIV-1-infected cells 
and anti-inflammatory effects, through cytokine modulation 
upon topical application.15–17 However, the exact mechanism 
of their anti-inflammatory effects is not fully understood.
Widespread application of nanomaterials holds   enormous 
potential for safe human exposure and environmental release. 
Elemental silver occurs naturally. It is considered non-toxic, 
non-allergic, is not cumulative, and is not known to harm 
either wildlife or the environment. Products made with silver 
nanoparticles have been approved by a range of authorities, 
including the US FDA, US EPA, the SIAA of Japan, Korea’s 
Testing and Research Institute for   Chemical Industry and the 
FITI Testing and Research Institute. Many consumer goods 
(eg, toys, baby pacifiers, clothing, food storage   containers, face 
masks, HEPA filters, laundry   detergent) already   incorporate 
silver NPs for their antimicrobial properties. While inges-
tion and skin penetration are potential exposure routes for 
engineered nanomaterials, the inhalation route for airborne 
nanomaterials has perhaps received the most attention.18,19
In the present study, we used a mouse model of allergic 
airway disease to evaluate the effect of silver NP inhalation 
on airway hyperresponsiveness and inflammation and to 
investigate the related molecular mechanisms.
Material and methods
Transmission electron microscope (TeM) 
imaging of silver NPs
For morphological studies of silver NPs, we had   assistance 
from the National Nanofab Center, Korea Advanced 
  Institute of Science and Technology in Daejeon. To enable 
the characterization of the samples using TEM imaging with 
a reasonable resolution, a silver NP solution was diluted in 
alcohol and was dispersed evenly for prevention of aggre-
gating particles and elimination of water. It was coated with 
mesh grid during imaging. The fine structure and particle 
size images of the silver NPs powder were obtained using a 
TEM (JEM-3020, 300 kV , JEOL, Japan).
Animals and experimental protocol
Female C57BL/6 mice, 8–10 weeks of age and free of murine 
specific pathogens, were obtained from Damul Science Inc. 
(Daejeon, South Korea) and were maintained under   standard 
laboratory conditions in a pathogen-free cage, with ad libitum 
access to food and water. All animal experiments in this 
study were conducted in accordance with the guidelines of 
the Institutional Animal Care and Use Committee of the 
Chungnam National University Medical School.
Mice were sensitized on days 1 and 14 via an   intraperitoneal 
(ip) injection of 20 µg of ovalbumin (OVA) (Sigma-Aldrich, 
St. Louis, MO, USA) emulsified in 1 mg of aluminum 
  hydroxide (Pierce Chemical Co., Rockford, IL, USA) in 
a total volume of 100 µL. On days 21–23 after the initial 
sensitization, the mice were challenged for 30 min with an 
aerosol of 3% (weight/volume) OVA in saline (or saline alone 
as a control) using an ultrasonic nebulizer (NE-U12, Omron, 
Japan). Bronchoalveolar lavage (BAL) was performed 
72 hours after the final challenge. At the time of lavage, the 
mice (8 per group) were sacrificed with an overdose of pento-
barbital sodium (100 mg/kg body weight, ip). The chest cavity 
was exposed to allow for expansion, after which the trachea 
was carefully intubated and the catheter was secured with 
ligatures. Pre-warmed 0.9% NaCl   solution was slowly infused 
into the lungs and withdrawn. The aliquots were pooled and 
kept at 4°C. A part of each pool was centrifuged, and the 
supernatant was kept at −70°C until use. Total cell numbers 
were counted using a hemocytometer. Smears of BAL cells 
were prepared using a cytospin (  Cellspin; Hanil Science 
Industrial Co, Ltd, Inchon, South Korea). To examine cell 
differentials, the smears were stained with Diff-Quik solution 
(Dade   Diagnostics of PR Inc, Aguada, Puerto Rico, USA). 
Two independent, blinded   investigators counted the cells 
under a microscope. Approximately 400 cells were counted in 
each of four random locations. The inter-  investigator variation 
was ,5%, and the mean number of cells from both counts 
was used to estimate cell differentials.
Administration of silver NPs
Silver NPs were obtained from Nano Chemical Inc. 
(  Daejeon, South Korea). Silver NPs were dissolved in PBS 
and   administered by nebulizer (20 ppm, 40 mg/kg body 
weight/day) five times to each animal at 24-hour intervals for 
5 days prior to each challenge day (days 19–24), beginning 
1 hour before the first challenge.
Determination of airway responsiveness
Airway responsiveness was evaluated 48 hours after the final 
challenge, with the mice in an unrestrained conscious state. 
The mice were placed in a barometric plethysmographic 
chamber (All Medicus Co., Seoul, Korea), and baseline 
readings were taken and averaged for 3 min. Increasing International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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concentrations (2.5–50 mg/mL) of aerosolized methacholine 
were nebulized through an inlet into the main chamber for 
3 min. Readings were taken and averaged for 2 min after 
each nebulization. Enhanced pause (Penh) was used as a 
measure of airway responsiveness to methacholine. Penh is 
a dimensionless value that represents a function of the pro-
portion of maximal expiratory to maximal inspiratory box 
pressure signals and a function of the timing of expiration. 
It was calculated according to the manufacturer’s protocol 
as: Penh = (expiratory time/relaxation time − 1) × (peak 
  expiratory flow/peak inspiratory flow). The results 
are expressed as the increase in Penh following challenge 
with each concentration of methacholine, where the baseline 
Penh (after saline challenge) is defined as 1.
hematology and blood chemistry
Blood samples were obtained within 24 hours after 
the administration of silver NPs by nebulizer (20 ppm, 
40 mg/kg body weight/day) five times to each animal at 
24 hour-  intervals for 5 days. Mouse blood or serum was 
obtained from female, BALB/c inbred mice. Hematologic 
parameters were analyzed in EDTA blood samples with 
XE-2100 (Sysmex, Kobe, Japan), hematology analyzer.
Blood chemistry was determined in serum samples from 
the control and silver NPs inhaled group 24 hours after silver 
NPs administration (by nebulizer, 20 ppm, 40 mg/kg body 
weight/day).
Measurement of intracellular rOs
ROS were measured using a previously described method.20 
BAL cells (1 × 104 cells) were washed in PBS, incubated for 
10 min at room temperature in PBS containing 3.3 µmol/L 
dichlorofluorescein diacetate (DCF-DA) (Molecular Probes, 
Eugene, OR, USA), transferred to polystyrene tubes with 
cell-strainer caps, and analyzed using a Cytomics FC 
500 CXP flow cytometry system (Beckman Coulter Inc., 
  Fullerton, CA, USA). We then measured the average percent-
age of cells that were either DCF-DA-unstained or -stained. 
Fluorescence images of intracellular ROS were acquired and 
analyzed using a fluorescence microscope (IX-71; Olympus 
Optical Co., Tokyo, Japan).
cytosolic or nuclear protein extraction 
for analysis of NF-κB p65
The lungs were removed and homogenized in 2 volume of 
buffer A (50 mmol/L Tris-HCl, pH 7.5, 1 mmol/L EDTA, 10% 
glycerol, 0.5 mmol/L dithiothreitol [DTT], 5 mmol/L MgCl2, 
and 1 mmol/L phenylmethanesulfonyl fluoride [PMSF]) 
containing protease inhibitor cocktail. The   homogenates were 
centrifuged at 1,000 × g for 15 min at 4°C. The supernatants 
from the homogenates were   incubated on ice for 10 min and 
centrifuged at 100,000 × g for 1 hour at 4°C, to obtain cytoso-
lic proteins for the analysis of NF-κB p65 levels. To prepare 
soluble nuclear proteins, the   pellets from the homogenate 
were washed twice in buffer A,   re-suspended in buffer B 
(1.3 mmol/L sucrose, 1.0 mmol/L MgCl2, and 10 mmol/L 
potassium phosphate buffer, pH 6.8), and centrifuged at 
1,000 × g for 15 min. The pellets were re-suspended in   buffer 
B with a final sucrose concentration of 2.2 mol/L and centri-
fuged at 100,000 × g for 1 hour. The resulting pellets were 
washed once with a solution containing 0.25 mol/L sucrose, 
0.5 mmol/L MgCl2, and 20 mmol/L   Tris-HCl, pH 7.2, and 
centrifuged at 1,000 × g for 10 min. These pellets were 
solubilized with a solution containing 50 mmol/L Tris-HCl 
(pH 7.2), 0.3 mol/L sucrose, 150 mmol/L NaCl, 2 mmol/L 
EDTA, 20% glycerol, 2%   Triton X-100, 2 mmol/L PMSF, 
and protease inhibitor cocktail. The mixture was kept on 
ice for 1 hour with gentle stirring and then centrifuged at 
12,000 × g for 30 min. The resulting supernatants were used 
as soluble nuclear proteins for the analysis of NF-κB p65. 
Protein levels were analyzed on Western blots, using an 
antibody against NF-κB p65 (Cell Signaling Technology, 
Beverly, MA, USA) as described above.
rNA isolation and rT-Pcr
Total RNA from lung tissues was isolated using a rapid extrac-
tion method (TRI-Reagent; Montgomery Rd, OH, USA) 
as previously described.21 NA was quantified by measuring 
absorption at 260 nm and was stored at −80°C before use. 
Total RNA (4 µg) was reverse-transcribed to cDNA in a buf-
fer containing 50 mM Tris-HCl (pH 9.0), 16 mM (NH4)2SO4, 
1.75 mM MgCl2, 0.1 M DTT; 1 µL oligo(dT) (500 µg/mL), 
10 mM dNTP, 40 units RNase inhibitor, and 1 µL SuperScript II 
RT (200 units/µL, Life Technologies, Grand Island, NY, USA), 
in a final vol of 20 µL. This   mixture was incubated for 50 min at 
42°C and was heated for 15 min at 70°C for enzyme inactiva-
tion. The first-strand cDNAs were used for PCR amplification 
of IL-4, IL-5, IL-13, or the housekeeping gene, GAPDH. PCR 
amplification was performed by mixing 3 µL of the RT   reaction 
mixture with 47 µL of buffer containing 2.5 U of Taq DNA 
polymerase (Promega, Madison, WI, USA) and 10 pmol of 
specific primer pairs for mouse cDNA of IL-4, IL-5, IL-13, or 
GAPDH, designed from published mouse gene sequences. The 
primers used were as follows: IL-4 (predicted length 400 bp) 
sense: 5′-CATCCTGCTCTTCTTTCTCGT-3′, antisense: 
5′-GTACTACGTGTAATCCATTTG-3′; IL-5 (predicted length International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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201 bp) sense: 5′-GAGCACAGTGGTGAAAGAGAC-3′, anti-
sense: 5′-ATGACAGGTTTTGGAATAGCATTT-3′; IL-13 (pre-
dicted length 182 bp) sense: 5′-GCCAGCCCACAGTTCTA 
CAGC-3′, antisense: 5′-  GTGATGTTGCTCAGCTCCTCA-3′ 
and GAPDH (predicted length 609 bp) sense: 5′-GCCA 
TCAACGACCCCTTCATTGAC-3′, antisense: 5′-ACG 
GAAGGCCATGCCAGTGAGCTT-3′. PCR reactions were 
performed in a thermocycler (GeneAmp® PCR System 2400, 
Foster City, CA, USA) using the following reaction conditions; 
after an initial incubation for 5 min at 95°C, samples were sub-
jected to 27 cycles (GAPDH) or 35 cycles (IL-4, IL-5, IL-13) 
of 5 min at 94°C, 30 sec at 60°C (GAPDH), 60°C (IL-4), 58°C 
(IL-5), 60°C (IL-13) and 1 min at 72°C. A final extension step 
at 72°C for 10 min was performed. The RT-PCR   products were 
electrophoretically fractioned on 2% agarose gels stained with 
ethidium bromide. DNA bands were visualized after exposure 
to UV light.
Western blot analysis
Lung tissues were homogenized in the presence of protease 
inhibitors, and protein concentrations were determined 
using the Bradford assay (Bio-Rad Laboratories Inc., 
Hercules, CA, USA). Samples were loaded onto a gel and 
subjected to SDS-PAGE at 120 V for 90 min. The separated 
  proteins were transferred to nitrocellulose membranes (GE 
Healthcare   Bio-Sciences, Piscataway, NJ, USA) via the wet 
transfer method (250 mA, 90 min). Nonspecific sites on the 
  membranes were blocked by incubation for 1 hour in 5% 
non-fat dry milk in Tris-buffered saline containing Tween 20 
(TBST; 25 mmol/L Tris, pH7.5, 150 mmol/L NaCl, 0.1% 
Tween 20), and the blots were then incubated overnight 
at 4°C with an anti-IL-4 antibody (Serotec Ltd, Oxford, 
UK), anti-IL-5 antibody (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), or anti-IL-13 antibody (R&D Systems, 
Inc.,   Minneapolis, MN, USA). Anti-rat or anti-mouse horse-
radish peroxidase-conjugated IgG was used to detect antibody 
binding. The membranes were stripped and re-probed with an 
anti-actin antibody (Sigma-Aldrich) to verify equal loading of 
proteins in each lane. Specific antibody binding was visual-
ized by exposure of the membranes to photographic film, after 
treatment with enhanced chemiluminescence system reagents 
(GE Healthcare Bio-Sciences, Piscataway, NJ, USA).
histological image analysis
For histological analysis, the mice were sacrificed 72 hours 
after the final challenge, and the lungs and trachea were filled 
with fixative (0.8% formalin, 4% acetic acid). The trachea 
was ligated, and the lungs and trachea were dissected out. 
The lung tissues were fixed with 10% (volume/volume) 
neutral-buffered formalin. Specimens were dehydrated and 
embedded in paraffin, and 4-µm-thick sections were cut using 
a Leica model 2165 rotary microtome (Leica Microsystems 
Nussloch GmbH, Nussloch, Germany). The sections were 
placed on slides, deparaffinized, and stained sequentially 
with hematoxylin 2 and eosin-Y (Richard-Allan Scientific, 
Kalamazoo, MI, USA). All stained slides were evalu-
ated via light microscopy under identical conditions with 
respect to magnification (20×), gain, camera position, and 
background illumination.22 The degrees of peribronchial and 
perivascular inflammation were scored by three independent, 
blinded investigators using a subjective scale of 0–3 (0, no 
detectable inflammation; 1, occasional cuffing with inflam-
matory cells; 2, most bronchi or vessels surrounded by a thin 
layer of between one and five inflammatory cells; 3, most 
bronchi or vessels surrounded by a thick layer of more than 
five inflammatory cells), as described elsewhere.23 Total lung 
inflammation was defined as the average of the peribronchial 
and perivascular inflammation scores.
Densitometric analysis and statistics
All immunoreactive signals were scanned and densitometric 
analyses were performed using a Gel-Pro Analyzer (Media 
Cybernetics, Silver Spring, MD, USA). Data are expressed 
as the mean ± SEM. Statistical comparisons were made 
using one-way analysis of variance (ANOVA) followed by 
Scheffe’s test. Significant differences between two groups 
were determined using an unpaired Student’s t-test. Statistical 
significance was set at P , 0.05.
Results
Morphological characterization  
of silver NPs
TEM was used to study the morphology and particle size 
of the silver NPs (Figure 1). The particles have a spherical 
shape. Mean particle size is 6.0 ± 0.29 nm.
Figure  1  A)  Photomicrographs  of  silver  nanoparticles  (NPs).  B)  Transmission 
electron microscopic image of bulk of silver NPs. Bars in A) and B) indicate 20 nm 
and 5 nm, respectively.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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effect of silver NPs on hematologic  
and serum chemistry profiles
To determine systemic effects of silver NPs, we introduced 
hematologic and serum chemistry profiles. For example, 
C-reactive protein, an acute-phase protein, is used as a bio-
marker of inflammation and lactate dehydrogenase is used as 
a marker of cytotoxicity. No significant changes in any of the 
hematological or serum chemistry parameters measured were 
observed in the inhalation exposure to silver NPs compared 
with the control (Tables 1 and 2). Only minor differences on 
serum chemistry levels were observed (Table 2).
effect of silver NPs on intracellular rOs 
levels in BAL cells from OVA-sensitized 
and OVA-challenged mice
Intracellular ROS generation was examined under a fluo-
rescence microscope, and ROS levels were quantified via 
FACScan analysis. ROS generation in BAL cells was sig-
nificantly higher at 72 hours after OVA inhalation compared 
with ROS generation after saline inhalation (31.3 ± 1.1 vs 
24.5 ± 1.4%, respectively). This increase in ROS generation 
was substantially attenuated by the administration of silver 
NPs (28.0 ± 1.2%) (Figure 2).
effect of silver NPs on NF-κB p65 
protein levels in lung tissues from  
OVA-sensitized and OVA-challenged mice
Western blot analysis showed a significant increase in 
NF-κB p65 in the nuclear protein extracts from lung tissues 
at 72 hours after OVA inhalation, compared with the level 
in control mice (Figure 3). This increase in NF-κB p65 
after OVA inhalation was decreased significantly with the 
administration of silver NPs. In contrast, NF-κB p65 in the 
cytosolic protein fractions from lung tissues was decreased 
after OVA inhalation, compared with the level in control 
mice, and this decrease in cytosolic NF-κB p65 was also 
attenuated by the administration of silver NPs.
effect of silver NPs on IL-4, IL-5,  
and IL-13 expression in lung tissues of 
OVA-sensitized and OVA-challenged mice
RT-PCR revealed that IL-4, IL-5, and IL-13 mRNA levels 
were increased substantially in lung tissues at 72 hours 
after OVA inhalation, compared with the levels after saline 
inhalation (Figure 4A). These increases were inhibited by the 
administration of silver NPs. Consistent with these results, 
Western blot analysis also demonstrated that cytokine levels 
in lung tissues were increased significantly at 72 hours after 
OVA inhalation, compared with the levels in control mice 
(Figures 4B and 4C) and that these increases were inhibited 
by the administration of silver NPs.
effect of silver NPs on cellular changes 
in BAL fluids and lung inflammation of 
OVA-sensitized and OVA-challenged mice
The numbers of total cells, eosinophils, lymphocytes, and 
neutrophils in BAL fluids were increased significantly at 
72 hours after OVA inhalation, compared with the cell counts 
after saline inhalation (Figure 5F), and the administration 
of silver NPs blocked these increases in cell counts after 
OVA inhalation. Similarly, the scores for total lung inflam-
mation were significantly increased at 72 hours after OVA 
inhalation, compared with the scores after saline inhalation 
(Figure 5E). The total lung inflammation scores after OVA 
inhalation were significantly lower with the administration 
of silver NPs.
effect of silver NPs on airway 
hyperresponsiveness
Airway responsiveness was assessed based on the increase 
in Penh in response to increasing doses of methacholine. 
Table 1 effect of inhalation exposure to silver NPs on hematologic 
profiles
SAL Ag P
WBc 3,530 ± 460.32 3,550 ± 625.539 0.98
rBc 8.60 ± 0.32 8.96 ± 0.47 0.55
hb 14.33 ± 0.16 13.66 ± 0.23 0.08
hct 41.96 ± 1.39  42.83 ± 0.81 0.62
PLT (×106) 4.13 ± 2.33 3.59 ± 5.34 0.42
Abbreviations: sAL, saline inhaled mice; Ag, silver NPs inhaled mice; WBc, white 
blood cell; rBc, red blood cell; hb, hemoglobin; hct, hematocrit; PLT, platelet.
Table 2 effect of inhalation exposure to silver NPs on serum 
chemistry profiles
SAL Ag P
TP 4.4 ± 0.72 4.44 ± 0.06 0.65
ALB 1.6 ± 0.03 1.62 ± 0.01 0.51
AsT 111.14 ± 14.18 153.16 ± 18.15 0.91
ALT 30.85 ± 1.1 34.33 ± 1.2 0.56
ALP 159.71 ± 5.56 139.14 ± 4.76 0.16
LDh 742.66 ± 82.39 841 ± 145.51 0.60 
crP 0.1 ± 0.00 0.1 ± 0.00 NA
BUN 18.18 ± 1.7 23.58 ± 2.44 0.14
creA 0.11 ± 0.01 0.13 ± 0.01 0.2
Abbreviations: sAL, saline inhaled mice; Ag, silver NPs inhaled mice; TP, total 
protein; ALB, albumin; AsT, asparte aminotransferase; ALT, alanine aminotransferase; 
ALP, alkaline phosphatase; LDh, lactate dehydrogenase; crP, c-reactive protein; 
BUN, blood urea nitrogen; creA, creatinine.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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In OVA-sensitized and OVA-challenged mice, the Penh 
  dose-response curve was shifted to the left compared with the 
control curve (Figure 6). In addition, Penh produced by the 
administration of 50 mg/mL methacholine was significantly 
greater in OVA-inhaled mice than in control mice. OVA-
sensitized and OVA-challenged mice treated with silver 
NPs showed a substantial reduction in Penh at 50 mg/mL 
methacholine compared with untreated mice after OVA 
inhalation. These results indicate that silver NP treatment 
reduces OVA-induced airway hyperresponsiveness.
Discussion
Bronchial asthma is a chronic inflammatory disease of the 
airways characterized by airway eosinophilia, goblet cell 
hyperplasia with mucus hypersecretion, and hyperrespon-
siveness to inhaled allergens and nonspecific stimuli.24,25 
There is increasing evidence that inflammation, which is 
characteristic of asthma, results in increased oxidative stress 
in the airways.26 Eosinophils, alveolar macrophages, and neu-
trophils from asthmatic patients produce more ROS than do 
those from normal subjects.27–30 ROS are involved in airway 
smooth muscle contraction, impairment of β-adrenergic 
receptors, decreased number and function of epithelial cilia, 
increased mucus production, altered release of inflamma-
tory mediators, influx of inflammatory cells, and increased 
vascular permeability.31
The overproduction of ROS or depression of protective 
mechanisms also results in bronchial hyperreactivity, which 
is characteristic of asthma.32–34 ROS directly cause contrac-
tion of airway smooth muscle preparations, and this effect 
is enhanced when the epithelium is injured or removed.32 
  Studies in animal models have indicated that ROS contribute 
to airway hyperresponsiveness by increasing vagal tone due 
to damage of oxidant-sensitive β-adrenergic receptors as well 
as decreased mucociliary clearance.35,36
ROS appear to directly stimulate the release of histamine 
from mast cells and mucus secretion from airway epithelial 
cells.37 Increased ROS release may directly result in oxida-
tive damage to epithelial cells and cell shedding.29 Previous 
  studies have suggested that ROS may lead to endothelial 
barrier dysfunction, with subsequent increased permeability 
to fluid, macromolecules, and inflammatory cells.31
The present study using an OVA-induced model of 
  allergic airway disease demonstrated that ROS   production 
Figure 2 effect of silver nanoparticles (NPs) on intracellular reactive oxygen species (rOs) levels in bronchoalveolar lavage (BAL) cells from ovalbumin (OVA)-sensitized and 
OVA-challenged mice. Sampling was performed 72 hours after the final challenge. A–D) Representative microphotographs show the dichlorofluorescein (DCF) fluorescence 
intensity of cells from saline-inhaled mice administered saline A), OVA-inhaled mice administered saline B), saline-inhaled mice administered 40 mg/kg of silver NPs (C), and 
OVA-inhaled mice administered 40 mg/kg of silver NPs D). E–H) corresponding transmission light microphotographs are shown. I–L) A representative frequency histogram 
of the fluorescence intensity of cells from saline-inhaled mice administered saline (SAL), OVA-inhaled mice administered saline (OVA), saline-inhaled mice administered 
40 mg/kg of silver NPs (Ag 40), and OVA-inhaled mice administered 40 mg/kg of silver NPs (OVA + Ag 40).
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was increased in cells from BAL fluids and that the 
  administration of silver NPs significantly attenuated ROS 
generation, Th2 cytokine expression, bronchial inflammation, 
and airway hyperresponsiveness in OVA-challenged mice.
We also noted that the increased levels of nuclear NF-κB 
induced by OVA inhalation were decreased with the admin-
istration of silver NPs. NF-κB is a multiprotein complex 
that is known to activate a large number of genes involved 
in early cellular defense reactions in higher organisms. In 
non-stimulated cells, inactive NF-κB is found in the   cytosol.38 
NF-κB plays an important role in immune and inflammatory 
responses and is present in most cell types.39–43 The role of 
ROS in the activation of NF-κB signal transduction was 
initially observed in cells treated with H2O2.44 A recent study 
reported that the development of an oxidant/  antioxidant 
imbalance in asthma leads to the activation of the redox-
sensitive transcription factor NF-κB.45 ROS have been 
directly implicated as second messengers in the activation of 
NF-κB, based upon the ability of oxidants to activate NF-κB 
via oxidation of its cysteine-SH group or via ubiquitination 
and proteolysis of IκB.46–48
NF-κB activation induces the transcription of a variety of 
inflammatory genes that are abnormally expressed in asthma, 
including cytokines (eg, IL-4, IL-5, IL-9, IL-15, and tumor 
necrosis factor [TNF]-α), chemokines (eg, regulated upon 
activation, normal T-cell expressed and secreted; eotaxin; and 
monocyte chemotactic protein-3), and   adhesion   molecules 
Figure 3 effect of silver nanoparticles (NPs) on the protein expression of NF-κB 
p65 in lung tissues collected from ovalbumin (OVA)-sensitized and OVA-challenged 
mice. NF-κB p65 were measured 72 hours after the final challenge in saline-inhaled 
mice administered saline (sAL), OVA-inhaled mice administered saline (OVA), saline-
inhaled mice administered 40 mg/kg of silver NPs (Ag 40), and OVA-inhaled mice 
administered 40 mg/kg of silver NPs (OVA + Ag 40). A) Western blot analyses of 
NF-κB p65 in nuclear (Nuc) and cytosolic (cyt) protein extracts from lung tissues. 
B) NF-κB p65 protein levels in (A) were quantified using a Gel-Pro Analyzer (Media 
cybernetics, silver spring, MD, UsA) and plotted as the integrated optical density, 
using Microsoft excel. Bars indicate the mean ± seM and are representative of eight 
independent  experiments  using  different  preparations  of  nuclear  and  cytosolic 
extracts. *P , 0.05 versus sAL; #P , 0.05 versus OVA.
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Figure 4 effect of silver nanoparticles (NPs) on IL-4, IL-5, and IL-13 expression 
in  lung  tissues  collected  from  ovalbumin  (OVA)-sensitized  and  OVA-challenged 
mice. Sampling was performed 72 hours after the final challenge in saline-inhaled 
mice  administered  saline  (sAL),  OVA-inhaled  mice  administered  saline  (OVA), 
saline-inhaled mice administered 40 mg/kg of silver NPs (Ag 40), and OVA-inhaled 
mice administered 40 mg/kg of silver NPs (OVA + Ag 40). A) rT-Pcr results. 
B) Western blot analyses of IL-4, IL-5, and IL-13 in lung tissues. C) Quantification 
of the IL-4, IL-5, and IL-13 protein levels in B) using gel-Pro Analyzer (Media 
cybernetics, silver spring, MD, UsA). The relative protein content was calculated as 
the ratio of the integrated optical density of each protein to that of actin. The ratio is 
arbitrarily presented as 100%. Bars indicate the mean ± seM and are representative 
of  eight  independent  experiments  using  different  preparations  of  lung  tissues. 
*P , 0.05 versus sAL; #P , 0.05 versus OVA.
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(eg, intercellular adhesion molecule-1 and   vascular cell 
  adhesion molecule-1).21,43,49,50 In a recent study, the anti-
oxidant L-2-oxothiazolidine-4-carboxylic acid (OTC) was 
shown to inhibit airway inflammation in a murine model 
of asthma.51 In that study, OTC administration significantly 
reduced NF-κB translocation into the nucleus and the expres-
sion of adhesion molecules, chemokines, and cytokines. 
These results show that OTC inhibits NF-κB activity by pre-
venting the ROS-induced translocation of this transcription 
factor into nucleus. Antioxidants have also been reported to 
inhibit NF-κB activation by preventing IκB   degradation in 
response to various stimuli.52–56 Taken together, these findings 
indicate that the activation of NF-κB by ROS is a critical 
signaling mechanism for evoking inflammatory responses.
Our results suggest that silver NPs attenuate   airway 
inflammation and hyperresponsiveness through the 
  modulation of ROS generation, which subsequently 
  attenuates the   expression of inflammatory cytokines and 
NF-κB activation in mice with allergic airway disease. 
Thus, silver NPs appear to act as antioxidative and/or anti-
inflammatory agents, based on this study. Nanocrystalline 
silver (NPI 32101) has been demonstrated to have anti-
inflammatory properties through both its topical and oral 
use, as shown in previous experimental studies.57–60 In these 
studies, nanocrystalline silver was shown to significantly 
suppress the expression of IL-β, IL-12, metalloproteinase-9, 
and TNF-α.57,59 When nanocrystalline silver was introduced 
intravesically in a rat cystitis model, it decreased the number 
of mast cells and the extent of mast cell degranulation.60 
However, there are also experiments showing that silver 
NPs induced inflammation.61,62 Proinflammatory cytokines, 
such as TNF-α, are rapidly secreted upon stimulation with 
various nanoparticles in macrophage RAW 264.7 cells.63,64 
It has been proposed that nanosilver modulates cytokine 
production in a concentration-dependent manner.62 These 
conflict between various studies regarding the properties 
of nanoparticles, including silver NPs, illustrate that the 
role of the immune system is still being clarified. Among 
various inorganic nanoparticles, gold nanoparticles, platinum 
nanoparticles, and nano red elemental selenium have been 
reported to show antioxidative effects.9–11,21–23 However, 
the precise mechanism of quenching induced by platinum 
nanoparticles remains unclear, and although selenium is 
one of the essential metals in the body, contamination with 
sodium serenite makes the use of nanoselenium difficult in 
Figure 5 Effect of silver nanoparticles (NPs) on bronchial inflammation in ovalbumin 
(OVA)-sensitized and OVA-challenged mice. sampling was performed 72 hours after 
the final challenge in saline-inhaled mice administered saline (SAL), OVA-inhaled mice 
administered saline (OVA), saline-inhaled mice administered 40 mg/kg of silver NPs 
(Ag 40), and OVA-inhaled mice administered 40 mg/kg of silver NPs (OVA + Ag 40). 
A−D)  representative  h&e-stained  sections  of  the  lungs.  Bars  indicate  scale  of 
50 µm. E) Total lung inflammation scores. F) The numbers of total and differential 
cellular components of bronchoalveolar lavage (BAL) fluids. Bars indicate the mean 
± seM for eight mice per group in four to six independent experiments. *P , 0.05 
versus sAL; #P , 0.05 versus OVA.
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Figure 6 effect of silver nanoparticles (NPs) on airway responsiveness to inhaled 
methacholine  in  ovalbumin  (OVA)-sensitized  and  OVA-challenged  mice.  Airway 
hyperresponsiveness was measured at 48 h after the final challenge in saline-inhaled 
mice administered saline (sAL), OVA-inhaled mice administered saline (OVA), saline-
inhaled mice administered 40 mg/kg of silver NPs (Ag 40), and OVA-inhaled mice 
administered 40 mg/kg of silver NPs (OVA + Ag 40). Penh values were obtained 
in  response to increasing doses (2.5–50 mg/mL) of methacholine.  Bars indicate 
the mean ± seM for eight mice per group in four to six independent experiments. 
*P , 0.05 versus sAL; #P , 0.05 versus OVA.
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biological applications. In the present study, we were unable 
to identify the exact mechanism underlying the effects of 
silver NP treatment, but the results of our 2′,7′-DCF-DA 
and FACS analysis support an antioxidative effect in this 
murine model of asthma. To our knowledge, this is the first 
report demonstrating the antioxidative effects of silver NPs. 
However, studies indicating that silver NPs may generate 
free radicals have also been published.65,66
Despite the potential usefulness of silver NPs as anti-
oxidative or anti-inflammatory agents, as indicated by this 
study, unresolved issues remain. First, the pharmacokinet-
ics of   silver NPs are not fully understood. Second, it is 
unclear where silver NPs scavenge ROS in the body of 
the mouse. That is, we did not determine the exact loca-
tion of silver NP activity at the cellular level. Third, it may 
be important to control the concentration of silver NPs 
in order to   scavenge only excess ROS and maintain the 
optimal ROS level. Fourth, controversy remains regarding 
the inflammatory/anti-  inflammatory effects of silver NPs. 
Recent studies have reported that silver NPs exerted anti-
inflammatory effects through the modulation of cytokine 
production,   particularly Th1 cytokines, and mast cell 
activation.57,60,62 Other studies have suggested that silver 
NPs have inflammatory effects.61,63,67 These   conflicting 
results may be attributable to several confounding factors 
such as particle size, surface charge, delivery method, route 
of administration, duration of administration, dose, and/or 
  disease conditions (intra/  extracellular milieu), which may 
alter the bioactive characteristics of nanoparticles in 
  particular cells or tissue types.
In summary, although further studies are needed, our 
study suggests that oxidative stress is an important determi-
nant of allergic airway disease and that silver NPs attenu-
ated oxidative stress in the murine asthma model. Also, by 
  administration of silver NPs, Th2 inflammation, which 
is one of the main asthma-inducing immune factors, was 
significantly decreased. We suggest that silver NPs may be 
useful as a therapeutic strategy through their properties as 
antioxidant and anti-inflammatory agents.
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